We would like to request from Royal Surrey County Hospital NHS Foundation Trust the numbers of patients treated in the last 12 months with the following drugs for the conditions listed below:
|Drug Name||Number of patients treated for:|
|Psoriasis||Psoriatic Arthritis||Ankylosing Spondylitis|
|Benepali (etanercept) – biosimilar|
|Remsima (infliximab) – biosimilar|
|Inflectra (infliximab) – biosimilar|
Request for Re-use
Please can you confirm whether we are permitted to reuse any information provided under the Open Government Licence? We (IMS Health) request permission to re-use as a part of an independent analysis into the use of biologics, which has been commissioned by one of our clients. The contents of the report will not be made available publically, but may be used by other IMS Health Group entities and service suppliers. The information in the report will be presented in a factual manner with all publication details staying true to the publisher. We acknowledge that information provided may be protected by copyright and will include a copyright statement to this effect at the end of any information we publish if requested by you.
The Royal Surrey County Hospital NHS Foundation Trust refuses the above request for re-use.
In the table below please find the total number of patients under the care of Rheumatology and Dermatology who have been treated with each of the drugs listed in the last 12 months for any indication. The total number of patients under the care of Rheumatology and Dermatology treated with the agents is listed as the Trust does not record the indication for treatment on the Pharmacy dispensing system. The data may, therefore, include patients who have been treated with these drugs for other indications. Where a drug is not listed it is because the Trust has not used it in the time period specified.